Cargando…
Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma
Clear-cell renal cell carcinoma (ccRCC) is a common aggressive urinary malignant tumor that cannot be easily diagnosed at an early stage. The DNA methylation occurs within promoter before precancerous lesion plays a pivotal role that could help us in diagnosing and understanding ccRCC. In this study...
Autores principales: | Gu, Yinmin, Zou, Yi Ming, Lei, Danqing, Huang, Yuanjie, Li, Weidong, Mo, Zengnan, Hu, Yanling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660223/ https://www.ncbi.nlm.nih.gov/pubmed/29079774 http://dx.doi.org/10.1038/s41598-017-14314-y |
Ejemplares similares
-
Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer
por: Tang, Yuanyuan, et al.
Publicado: (2017) -
Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion
por: Xin, Xianxiang, et al.
Publicado: (2017) -
CpG island hypermethylation go circular (RNA)
por: Dragomir, Mihnea P., et al.
Publicado: (2018) -
Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014) -
A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines
por: Hesson, Luke B, et al.
Publicado: (2012)